Others reported increased GP73 serum levels in Hcc and increased tissue levels in adenocarcinomas of prostate, colon, breast, and some types of renal cell carcinomas indicating thatGP73 is not a specific biomarker for HCC.16 This evidence concerns the gene HYCC1 and prostate adenocarcinoma.